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MicroarraySilencing of tissue-speciﬁc gene expression in mammalian somatic cell hybrids is a well-documented
epigenetic phenomenon which is both profound (involving a large number of genes) and enigmatic. Our aim
was to utilize whole-genome microarray analyses to determine the true extent of gene silencing on a
genomic level. By comparing gene expression proﬁles of hepatoma×ﬁbroblast cell hybrids with those of
parental cells, we have identiﬁed over 300 liver-enriched genes that are repressed at least 5-fold in the cell
hybrids, the majority of which are repressed at least 10-fold. Also, we identify nearly 200 ﬁbroblast-enriched
genes that are repressed at least 5-fold. Silenced hepatic genes include several that encode transcription
factors and proteins involved in signal transduction pathways. These data suggest that extensive
reprogramming occurs in cell hybrids, leading to a nearly global (although not complete) loss of tissue-
speciﬁc gene expression.l rights reserved.© 2010 Elsevier Inc. All rights reserved.1. Introduction
Mechanisms responsible for establishment and maintenance of
tissue-speciﬁc gene expression have been well studied over several
decades, yet the basic processes leading to the differentiated state have
remained largely unknown. In the mammalian liver, several hepato-
cyte-speciﬁc transcription factors have been identiﬁed that bind to
liver-speciﬁc genes and drive their transcription [1,2]. The hepatocyte-
enriched factors include a homeodomain protein (HNF1A), a winged
helix factor (FOXA2/HNF3B), an orphan nuclear receptor (HNF4A),
and a one cut homeodomain protein (ONECUT1/HNF6) [3–5]. It has
been well established that these transcription factors function in
regulatory networks, such that several factors bind to a givenpromoter
[2,6]. Also, regulatory loops have been identiﬁed, such as HNF4A and
HNF1A, which reciprocally bind each to other's promoters, and HNF6
binding to the HNF4A promoter [6–9].
Nearly 35 years ago, results of experiments examining silencing of
tissue-speciﬁc genes in somatic cell hybrids and subsequently in cell
variants were ﬁrst reported [10,11]. The fusion of distinct cell types
normally results in silencing of tissue-speciﬁc gene expression (a
phenomenon termed extinction). This gene silencing is often revers-
ible, either by extensive loss of ﬁbroblast chromosomes or, in rare
circumstances, by ectopic expression of tissue-speciﬁc transcription
factors [11–14]. Silencing only occurs if cell types are of distinct origin
(e.g. hepatic vs. monocyte), but themammalian species used is largely
irrelevant.Taken as a whole, four patterns emerge from the literature:
Extinction of gene expression is described as global (all or nearly all
tissue-speciﬁc genes, but not house-keeping genes, are silenced in cell
hybrids) [12], bidirectional (tissue-speciﬁc genes of both parental
cells are silenced), reversible (loss of large sets of chromosomes in
unstable hybrids will result in re-expression of silenced genes)
[12,15,16] and transcriptional (silencing occurs at the level of
transcription) [17–19].
Extinction is thought to involve regulatory control mechanisms
which restrict expression of particular genes to speciﬁc cell types
during development [20,21]. Although extinction of tissue-speciﬁc
gene expression in cell hybrids has been well documented [17,18],
limited progress has been made in identifying either the genetic
components involved or the cis-acting DNA sequences that are
targeted during this process. Several recent reports have described
the fusion of embryonic stem cells (ESCs) with somatic cells, in which
the resulting cell hybrids exhibit silencing of tissue-speciﬁc genes as
well as reprogramming to the pluripotent phenotype in the ESC
(reviewed in [22].
It has long been observed that promoters of genes which are
expressed in a tissue-speciﬁc fashion are inactive when transfected
into hybrid cells [23–27]. This result suggests that extinction is
mediated through tissue-speciﬁc regulatory sequences located within
promoter sequences. Indeed, studies of growth hormone [23], insulin
[27], immunoglobulin [26], α1-antitrypsin [25] and tyrosine amino-
transferase [28] gene expression in hybrids have shown that
extinction is accompanied by the loss of essential trans-acting factors
speciﬁc to various tissue types. This has been taken to suggest that
extinction of these genes is causally related to the loss of these
transactivators [20,21,27,29]. Two examples of a lack-of-activation
phenotype have been reported. First, silencing of some B-cell speciﬁc
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((POU2F2) expression [30]. Second, we and others have shown that
silencing of HNF1A expression in hepatoma×ﬁbroblast hybrids is
prevented by ectopic HNF4A expression [8,31].
With the exceptions of the ability to rescue HNF1A and OCT2 genes
with introduction of transactivators in cell hybrids, extinction of most
genes is driven by unknownmechanisms. For example, the SERPINA1
gene is extinguished despite introduction of essential trans-acting
factors HNF1A and HNF4A [25,32,33]. This is unexpected, since HNF1A
and HNF4A were reported to be the major activators of SERPINA1
gene expression in hepatoma cells [25,34–36]. Furthermore, analyses
using panels of rat hepatoma cells containing a single or few human or
mouse ﬁbroblast chromosomes have identiﬁed additional putative
extinguisher loci for PCK2 gene and albumin genes, but other
extinction phenotypes were not obvious [37–39].
Recent technologies including microarrays and chromatin immu-
noprecipitation (ChIP) assays have allowed for the mapping of
transcriptional regulatory circuitry in eukaryotic cells. For example,
such regulatory circuits in the mammalian liver have identiﬁed the
extent to which known master regulatory genes of the liver encode
proteins that bind to and activate liver-speciﬁc genes. Odom et al.
used these techniques to show that major transcriptional proteins in
hepatocytes (HNF1A, HNF4A, FOXA2, HNF6 and CREB1) operate in a
synergistic fashion to drive expression of hundreds of hepatic genes
[1], as well as functioning in autoregulatory loops to activate
expression of each other [6] (Fig. 1). Likewise, others have mapped
additional regulatory circuitry in hepatocytes [9,40,41]. However,
identiﬁcation of genes controlling the master regulators in hepato-
cytes has remained elusive. In order to characterize the extinction
phenotype and better understand epigenetic reprogramming, we
proﬁled genome-wide expression in a well-characterized cell hybrid
system, comparing expression in rat hepatoma cells, rat ﬁbroblasts
and hepatoma×ﬁbroblast hybrids.
2. Materials and methods
2.1. Cell lines and culture conditions
The FTO2B cells are a thymidine kinase negative derivative of H4IIE
cells, originally isolated in 1970 from a rat tumor in the laboratory of
Mary Weiss (Pasteur Institute). The RAT1 cells are a continuous cell
line obtained by SV-40 large T antigen transformation of normal rat
ﬁbroblasts. Unlike many tumor cell lines, both RAT1 and FTO2B cells
show little evidence of chromosomal rearrangements or anueploidy
common to tumor cells. All cells were maintained in 1:1 Ham's F12/
Dulbecco's modiﬁed Eagle's medium (FDV) containing 5% fetal bovine
serum (FBS) (GIBCO BRL) and 5 μg/100 ml penicillin-streptomycin
(GIBCO) at 37 °C in a humid 5% CO2 chamber.
2.2. Generation of hepatoma×ﬁbroblast hybrids
FTO2B cells were plated with RAT1 cells (106 of each cell type).
After 24 h, the mixed cell monolayers were fused using 50%
polyethylene glycol (50%w/v) for 1 min. The following day, cells
were split 1:20 into medium containing 3 mM Ouabain and
Hypoxanthine-Aminopterin-Thymidine (HAT) medium to selectFig. 1. Transcriptional regulation of genes involved in hepatic regulatory circuitry. Auto- a
transcription factors. Modiﬁed from Odom et al. [6].against ﬁbroblast and hepatoma parents, respectively. After 2–
3 weeks, surviving cell hybrid clones were pooled (N100 clones/
pool) and expanded in HAT medium.
2.3. Chromosome spreads
To analyze cell hybrids for complete karyotypes, subconﬂuent cell
monolayers were exposed to 0.05uM colcemid (a mitosis inhibitor)
for 40 min and cells harvested. Cells were incubated to 0.075 MKCl for
10 min and then treatedwithmethanol/acetic acid (3:1) as previously
described [32]. Cells were dropped onto cold, wet slides then the
slides stained with crystal violet and scored for chromosome numbers
per spread for 10–15 spreads.
2.4. RNA extraction
RNA was extracted from nearly-conﬂuent monolayers using a
Qiagen RNeasy Mini Kit (Cat #74104) following the kit protocol with
the addition of a DNAseI (Cat #79254) digestion step, as per protocol.
Brieﬂy, approximately 107 cells were lysed with RLT buffer, samples
spun through a Qiagen column shredder to ensure homogenization,
and RNA collected on an RNEasy column. Samples were washed and
then digested with DNase I for 15 min at RT. RNA was further washed
then eluted. RNA integrity was determined by 28S and 18S rRNA
visualization following gel electrophoresis in MOPS with 1% agarose–
2.2 M formaldehyde gels, as described [42]. RNA purity and
concentration was determined by nano-drop spectrophotometery at
260 and 280 nm. Duplicate samples of each cell line used for
microarray analysis were extracted on different days.
2.5. Microarray analysis
RNA microarrays were processed by the W. M. Keck Center for
Comparative and Functional Genomics in the Roy J. Carver Biotech-
nology Center at the University of Illinois at Urbana-Champaign. RNA
was prepared and hybridized to Affymetrix GeneChip Rat Genome
230 2.0 Expression Arrays (Affymetrix, Inc., Santa Clara, CA) in the
Functional Genomics unit utilizing the GeneChip Expression 3’
Ampliﬁcation One-Cycle Target Labeling and Control Reagents kit,
according to the manufacturer's instructions. Brieﬂy, eight micro-
grams of total RNA was spiked with four prokaryotic polyadenylated
sense RNA controls, primed with a T7-(dT)24 oligonucleotide
containing a 5’ T7 promoter sequence, and reverse transcribed to
double-stranded cDNA. Following puriﬁcation cDNA was in vitro
transcribed and ampliﬁed, generating pseudouridine-biotinylated
cRNA. The cRNA was puriﬁed and fragmented. Hybridization cocktails
were prepared, adding biotinylated, fragmented controls consisting of
four prokaryotic antisense cRNAs and one synthetic oligonucleotide.
Following a 16-h hybridization the chipwaswashed, stained ﬁrst with
streptavidin-conjugated phycoerythrin dye (Invitrogen Corporation,
Carlsbad, CA), and the stain enhanced with biotinylated goat anti-
streptavidin antibody (Vector Laboratories, Burlingame, CA), then
counterstained with the conjugated phycoerythrin, utilizing a
GeneChip Fluidics Station 450 and the GeneChip Operating Software
version 1.4. The chips were scanned with a GeneChip Scanner model
3000 7G Plus. Files of the ﬂuorescence signals were generated, qualitynd cross-regulation are a common theme in modulating expression of liver-enriched
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matics unit for statistical analysis.
2.5.1. Reverse transcription polymerase chain reaction (RT-PCR)
The standard two-step RT-PCR protocol in the MasterAmp High
Fidelity RT-PCR kit (Epicentre Biotechnologies) was used for the
synthesis of cDNA from puriﬁed RNA. Reverse transcription reactions
with the test RNA samples contained 19 μl sterile nuclease-free H2O,
3 μl RNA, 25 μl MasterAmp 2X RT-PCR PreMix, 2 μl Oligo DT and 1 μl
Moloney Murine Leukemia Virus Reverse Transcriptase (MMLV-RT).
The control mix contained 22 μl sterile nuclease-free H2O, 25 μl
MasterAmp 2X RT-PCR PreMix, 1 μl MMVL-RT, and 1 μl control mix.
The mixes were stored on ice before starting the reaction Samples
were then incubated at 37 °C for 30 min.
PCR was run using the cDNA synthesized. All primer pairs used
were complementary to exonic sequences that spanned intronic
regions in order to limit the possibility of genomic DNA ampliﬁ-
cation giving rise to false positive signals for RNA production. For
the test RNA, 2.5 μl of cDNA was added to 1 μl of 12.5 μM forward
gene speciﬁc primer, 1 μl of 12.5 μM reverse gene speciﬁc primer,
12.5 μl of GoTaq (Promega), and 8 μl H2O. Primers sequences used
for RT-PCR are as follows: Albumin: for-5'ctagcctctggcacaatgaagt 3',
rev-5'cttaaaccgatgggcgatctcact 3’; Hprt1: for-5'agcggcaagttgaatcta
3', rev-5'agtgaaatctacctgac 3': Pah: for-5'tcgctatgacccttacactc 3',
rev-5'ggttgacctcctaagttctg 3'; Hnf6: for-5'agccctggagcaaactcaagtcc
3', rev-5' gtccaacgtcggactctacatgca 3'; Transferrin (Tf): for-5'
tggctcaggaacactttg 3', rev-5' tcccgctga tttcgaatg 3'; Gapdh: for-
5'cagtgccagcctcgtctcat 3', rev-5'aggggccatccacagtcttc 3'. The control
for the PCR contained 10 μl of control cDNA mix, 1 μl of TaQuarate,
and 14 μl H2O. The thermocyclerwas set for 30 cycleswith a denature
temperature of 92–95 °C for 30 s, annealing temperatures at 2–5 °C
below Tm of the primers for 30 s, followed by extension of the
annealed primers at 68–72 °C for 45–60 s for every kb of expected
product. Also, a ﬁnal extension step was performed at 72 °C for 4–
7 min. After ampliﬁcation, samples were visualized using 1.5%
agarose gel electrophoresis with ethidium bromide staining.
3. Results
In order to determine the full extent of gene silencing in somatic
cells hybrids, FTO2B rat hepatoma cells were fused with rat RAT1
ﬁbroblast cells to generate FR hybrids. Selective medium was used to
select against survival of parental cells (see Materials and methods)
and cell hybrids pooled and expanded. To verify that the cell hybrids
were true hybrids, karyotype analysis was carried out on parental and
hybrid cells. As expected, the parental cells averaged 44 chromosomes
and the hybrid cells averaged 87 chromosomes (Table 1). Thus, the
hybrid cells appear to contain the full complement of chromosomes
from both parents results are consistent with previous karyotype
analysis of cell hybrids [25,32].
With the intention of determining the viability of the whole-
genome approach in evaluating extinction of gene expression in
somatic cell hybrids, we carried out duplicate experiments using rat
hepatoma, rat ﬁbroblast and hepatoma×ﬁbroblast hybrid cells. For
microarray analysis, RNA was obtained from cultured cells and
reverse transcribed into cDNA. cDNA was then ampliﬁed, biotinylated
and then hybridized to Affymetrix 2.0 whole rat genome microarray
chips, representing over 31,000 transcripts (some targets areTable 1
Karyotype analysis of parental and hybrid cells.
Cell type Description Chromosomes retained mode (range)
FTO2B Rat hepatoma parental 44 (36–48)
RAT1 Rat ﬁbroblast parental 44 (43–55)
FR hybrid FTO2B×RAT1 hybrid 87 (83–98)represented multiple times). Chips were stained with strepavidin-
conjugated phycoethrin dye, read using an Affymetrix laser scanner
and analyzed using Affymetrix statistical software.
3.1. Microarray assay reproducibility
To examine reproducibility of the microarray assay, we compared
biological replicates for each cell line. We used RNA extracted from
the same cell lines but on separate days. Of the panel of over 50
control genes included in the analysis, including several endogenous
genes and spiked samples, variation in signal strength for each control
gene was less than 2-fold in all samples, including signals from
housekeeping genes β-actin and GAPDH. The exception was hexoki-
nase gene expression which was 3–16× higher in ﬁbroblast and
hybrid cell lines, respectively, compared to the hepatoma parent cell
line (data not shown).
Analysis of the entire genome showed a signiﬁcant number of
genes with N2 fold differences in duplicate experiments using the
same cell line, including 1%–4% of approximately 14,000 expressed
genes (signal strength of N100 units) (Fig. 2). However, genes
showing N5 fold differences between replicates were minimal, with
only 4 to 12 genes represented in any of the duplicate comparisons
(Fig. 2). As it is those genes that exhibit a greater than 5-fold
difference in expression levels between cell types that were the focus
of this analysis of gene silencing, these results suggest a very low
number of false positives that could interfere with the analysis.
Validation of micraoarray results was carried out using reverse-
transcription PCR on select genes. Expression proﬁles for several
genes were obtained. As an example, expression of four liver-enriched
genes and two housekeeping genes (encoding HPRT1 and GAPDH) are
shown to highlight variability in the assay (Fig. 3). Both Gapdh and
Hprt1 showed similar signals in all three cell lines tested, whereas
expression of other genes was detected in the hepatoma cells, but not
in the ﬁbroblasts cells. In agreement with microarray data, transferrin
gene expression was also observed in the cell hybrid. Unexpectedly,
PAH expression was observed in the FR hybrids, despite lack of
detectable expression by microarray.
3.2. Analysis of cell-type speciﬁc gene expression
We next determined the number of genes expressed in a cell-
speciﬁc fashion (FTO2B vs. RAT1). Our criteria required mean gene
expression signals to be N500 units in one cell line and b100 units in
the comparison cell line. Using these criteria, both ﬁbroblast and
hepatoma cells showed approximately 92–94% of the 14,000 genes
expressed in one cell type are expressed at least marginally (N100
units) in the other cell type, the majority (80%) expressed at N500U
(Fig. 4). Importantly, only 5–8% of genes expressed at N500 units in
one cell type were expressed at b100 units in the other cell type. Thus,
this latter set of geneswas considered to be expressed in a cell-speciﬁc
manner. Of these, a large number of genes are expressed at high levels
(N5000 units) (data not shown).
3.3. Silencing of hepatoma-speciﬁc genes in cell hybrids
We next examined extinction proﬁles in the hepatoma×ﬁbroblast
cell hybrids (termed FR hybrids). Previous analyses have identiﬁed
several genes that are strongly repressed in these and similar cell
hybrids [12,43]. However, a comprehensive study has not been
reported. Microarray data identiﬁed 330 genes that are moderately to
highly expressed in hepatoma cells (N500U) and that are repressed at
least 5 fold in the hybrid cells, 213 of which are repressed dramatically
(N10-fold) (Fig. 5). These include several genes previously reported to
be silenced in cell hybrids, including α1-antitrypsin, albumin, and
phenylalanine hydroxylase. Indeed, signal intensities for each of these
genes dropped from N12,000 units to b50 units (Table 2). Notably,
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Fig. 2. Reproducibility of the microarray analysis. (A) Comparison of scatter plot data between replicate samples for FTO2B, RAT1 and FR cells whole genome data. Chip-to-chip
variation is minimal is duplicate experiments, with very little scatter in the top right quadrant, representing genes expressed at greater than 100Units. Slanted lines emanating from
the center line represent 2-, 3-, 5- and 10-fold differences in signal values between the replicates. (B) Chip-to chip variation within a cell line is less than 3-fold in all but
approximately 100 genes, and less than 5-fold in all but a few (between 4 and 12 genes). FTO2B=hepatoma; RAT1=rat ﬁbroblasts; FR=hepatoma×ﬁbroblast hybrids.
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as Expressed Sequence Tags (ESTs) (data not shown).
Whilemost hepatoma-speciﬁc genes are not expressed (b100U) in
the cell hybrids, a number of these genes are not fully silenced in the
cell hybrids, including those encoding retinol binding protein, alcohol
dehydrogenase class I, and transferrin (Table 2). Of the 330 repressed
hepatic genes, only 158 (48%) showed expression levels below 100
units in the hybrid cells. Of the remaining 172 genes that showed
expression (N100 U), 51 were also expressed at least modestly
(N100 U) in the parental RAT1 cells. This latter result is consistent
with previous results showing that genes expressed in both cell types
remain expressed in cell hybrids [17]. Unexpectedly, 119 genes werenot expressed (b100 U) in the RAT1 cells, yet were expressed
(N100 U) in the hybrid cells (several above 500 U). Thus, while
most liver-speciﬁc genes appear to be silenced in the hybrids, a
substantial number of genes maintain at least a modest level of
expression in the cell hybrids, despite being silent in the ﬁbroblast
cells (data not shown).
3.4. Silencing of ﬁbroblast-speciﬁc genes in cell hybrids
One of the tenants of extinction in somatic cell hybrids is that it is
bi-directional (i.e. tissue-speciﬁc gene expression of both parental cell
types is silenced in the fusion cell), although only limited reports are
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Fig. 3. Validation of expression proﬁles of select genes. RT-PCR was carried out to monitor expression levels of select genes. RNAs were revere-transcribed and the cDNAs
ampliﬁed using gene-speciﬁc primers (see Materials and methods). Genes tested included two housekeeping genes (Hprt1 and Gapdh, left panel) and four liver-enriched
genes (Alb, Pah, Transferrin and Hnf6, right panel). Alb=albumin; Pah=Phenylalanine hydroxylase; Tf=transferrin. FTO2B=hepatoma; RAT1=rat ﬁbroblasts;
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Fig. 4. Comparison of cell-speciﬁc expression in hepatoma, ﬁbroblasts and cell hybrids. (A) Scatter plot comparing gene expression proﬁles with the other two cell lines. Slanted lines
emanating from the center line represent 2-, 3-, 5- and 10-fold differences in signal values between the assays. (B) Summary of number of genes that show N500U in FTO2B (left) or
RAT1(right) and are not expressed (b100U), are modestly expressed (100–500 U), or are moderately to highly expressed (N500 U) in the RAT1 or FTO2B cells, respectively. For
example, 5.6%, 14.4% and 80% of FTO2B-specifc genes are not expressed, expressed at low levels, or highly expresssed in the RAT1 cells, respectively. FTO2B=hepatoma; RAT1=rat
ﬁbroblasts; FR=hepatoma×ﬁbroblast hybrids.
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what extent. Previous studies have focused on loss of hepatic gene
expression in cell hybrids. Our analysis indicates that a large number
of ﬁbroblast-speciﬁc genes are strongly repressed in cell hybrids.
Microarray results identiﬁed 198 genes that were expressed at least 5-fold lower in the FR cells, 74 of which were reduced N10-fold (Fig. 5).
Of these 198 genes, 67 were repressed to levels below 100 units.
Interestingly, only 35% of these 198 genes have been functionally
identiﬁed. In contrast, 61% of the 213 hepatoma-speciﬁc genes
repressed N10 fold in hybrids have been identiﬁed.
Fig. 5. Extent of gene repression in cell hybrids. The number of hepatoma-speciﬁc
and ﬁbroblast- speciﬁc genes repressed at N5- and N10-fold levels in the cell hybrids
are shown. Genes expressing less than 500 units in parental cell lines were not
included in the analysis. Ratios of expression value means were used to determine
values. FT/FR=ratio of mean expression values of FTO2B hepatoma cells to FR cell
hybrids. RAT1/FR=ratio of mean expression values of RAT1 ﬁbroblasts cells to FR
cell hybrids.
Table 2
Expression levels of select identiﬁed liver‐enriched genes in FTO2B, RAT1 and FR hybrid
cell lines. Values shown are mean values.
Designation FTO2B RAT1 FR FT02B/FR
ratio
1387314_at 943 6 1 1178 Dopatyrosine sulfotransferase
1387034_at 14,399 4 12 1161 Phenylalanine hydroxylase
(Pah)
1367555_at 30,376 37 27 1121 Albumin (Alb)
1372264_at 12,435 30 18 703 PEPCK (Pck2)
1369701_at 3497 3 6 573 Lipase, hepatic (Lipc)
1367647_at 11,512 21 24 479 alpha-1 Antitrypsin (SerpinA1)
1367758_at 853 3 2 461 alpha-Fetoprotein (Afp)
1368161_a_at 10,564 20 43 247 alpha-2-HS-glycoprotein
(Ahsg)
1387811_at 2722 10 23 117 Angiotensinogen (Agt)
1387760_a_at 684 11 6 110 Hepatocyte nuclear factor 6
(Onecut1)
1368360_at 3121 44 31 100 Plasminogen (Plg)
1370377_at 1681 8 25 68 Cytochrome P450CMF1b
1370299_at 569 18 15 37 Aldolase B, fructose-
biphosphate (Aldob)
1368711_at 4287 11 148 29 Hepatocyte nuclear factor 3
beta (Hnf3b)
1370547_at 1236 15 45 28 alpha-1-Macrogloculin
1367939_at 6205 18 239 26 Retinol-binding protein 1
(Rbp1)
1383904_at 3260 24 127 26 Fibrinogen gamma (Fga)
1370992_a_at 4031 23 159 25 Fibrinogen, A alpha polypeptide
(Fga)
1371089_at 857 17 40 21 Glutathione-S-transferase, alpha
Yc (Gsta2)
1368622_at 828 14 39 21 Fructose bisphosphatase 2
(Fbp2)
1368021_at 28,815 3907 1437 20 Alcohol dehydrogenase (class I)
(Adh1a)
1387819_at 8686 97 452 19 Elastase 1 (Ela1)
1370511_at 5986 1 315 19 Fibrinogen B beta chain (Fgb)
1367598_at 1088 72 62 18 Transthyretin (Ttr)
1369171_at 713 25 44 16 Hepatocyte growth factor-like
(Mst1)
1369072_at 1438 106 91 16 Alcohol dehydrogenase 7 (class
IV) (Adh7)
1370964_at 11,908 7 1021 12 Arginosuccinate synthetase 1
(Ass)
1370065_at 12,091 40 1046 12 Hemopexin (Hpx)
1368672_at 747 31 84 9 Arginase type II (Arg2)
1368467_at 4260 11 642 7 Cytochrome P450 4F1 (Cyp4f1)
1370148_at 979 62 151 7 Haptoglobin (Hp)
1370228_at 24,893 7 4630 5 Transferring (Tf)
1386904_a_at 14,492 3465 2715 5 Cytochrome B5 (Cyb5)
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Several reports have clariﬁed the role of core transcriptional
regulatory proteins in driving hepatic gene expression [1,6,9,41].
Four master regulators in human hepatocytes have been identiﬁed,
including Hepatocyte Nuclear Factors HNF1A, HNF3B (FOXA2),
HNF4A and HNF6. Odom et al. [6] used chromatin immunoprecip-
itation and microarray analysis to show that these factors operate
combinatorial to activate hepatic gene expression, each binding to
800–4000 gene promoters.
As expected, each of the HNF genes was expressed in the
hepatoma cell line, silent in the ﬁbroblast cells, and repressed in the
cell hybrids. Signals for several transcription factor genes Foxa1
(Hnf3A, Foxa3, and most Cebp genes) were below detection in any of
the cell types (results not shown). Other genes, including Hnf1A and
Hnf4a, were expressed at low levels in hepatoma but at 3- to 10-fold
lower in cell hybrids (see Fig. 6). Two genes in particular, HNF6 and
HNF3β, were expressed at high levels (3000–4500 Units) in the
hepatoma cells, but undetectable levels in ﬁbroblasts and cell hybrids.
For comparison, we included expression of the ubiquitously active
transcription factor Usf1, whose product is also important in liver
function [44]. Results show that Usf1was expressed at nearly identical
levels in both parental and hybrid cells.
In an attempt to identify other candidate genes that might be
involved in gene silencing, we next screened those genes that were
repressed at least 5 fold in the cell hybrids for function. Genes that
were known to be components of transcriptional activation path-
ways were analyzed. Eight genes were identiﬁed in this analysis,
including Hematopoietically Expressed Homeobox (Hhex), Wnt4, a
Wnt-2-like gene,Wnt inhibitory factor-1 (Wif1), lymphoid enhancer
binding factor-1 (Lef1), growth hormone–releasing hormone
(Ghrh), growth hormone receptor (Ghr) and insulin-like growth
factor binding protein 1 (Igfbp1). Each showed a pattern of
expression similar to the HNF genes (Fig. 6, and data not shown).
Likewise, several ﬁbroblast-speciﬁc genes encoding transcription
factors were identiﬁed that are silenced in the cell hybrids, including
pmx-1(Prrx1), Bmp3, Ebf1, Edg2 (Bud31) and Shox2 (Fig. 6).
4. Discussion
Studies analyzing the phenomenon of gene silencing in mamma-
lian somatic cell hybrids over several decades have led to a number of
observations. The most striking aspect is the degree of silencing of
speciﬁc genes. In most cases, expression of assayed tissue-speciﬁc
genes was undetectable in the cell hybrids. This observation was
accompanied by reports showing that several tissue-speciﬁc genes
were silenced in hybrids [11,12]. With the discovery of cell-type
speciﬁc transcription factors, it was assumed that silencing of most
genes in cell hybrids was due to the loss of these tissue-enriched
transcription factors. Indeed, one putative extinguisher, TSE1, was
identiﬁed as the regulatory subunit of protein kinase A (PKA) and that
its overexpression in hepatoma cells would recapitulate at least a
portion of the silencing phenomenon in hepatoma×ﬁbroblast hybrids
[45,46]. However, TSE1 was found to be insufﬁcient for complete
silencing of target genes and its affect could be readily reversed by
activation of the cAMP pathway [47], making it unlikely that TSE1
could account for the extinction phenotype in cell hybrids. Other
direct tests of the hypothesis that loss of transcription factors is
responsible for gene silencing have proven to be largely invalid,
although silencing of select genes (actually other transcription
factors) could be reversed by the introduction of missing transcription
factors [8,30].
A systematic whole-genome approach to study the epigenetic
phenomenon of gene silencing in cell hybrids and cell variants has not
been reported, partially due to the fact that most of previous studies
have been carried out using non-human cells and that whole genome
Fig. 6. Silencing of tissue-speciﬁc transcriptional regulators in cell hybrids. Mean expression values for genes encoding for known tissue-speciﬁc transcription factors are shown. Usf1
gene expression values are included for comparison. One uncharacterized gene that showedmarked hybrid-speciﬁc gene expression is included (labeled “EST”). FTO2B=hepatoma;
RAT1=rat ﬁbroblasts; FR=hepatoma×ﬁbroblast hybrids.
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hybrid cells (termed FR) described here were derived using selection
against growth of either parental cell line. Unlike many hybrid cell
types that have been generated, the FR cells have proven to be very
stable, with a stable genotype that rarely demonstrates chromosome
loss (unpublished observation). Thus, the fact that both parental cells
are of rat origin and the hybrid genotype and phenotype are very
stable makes this a useful model by which to apply whole-genome
microarray analysis.
Our approach was to use rat whole genomemicroarrays to analyze
the well characterized rat cell-based studies to understand the full
extent of gene silencing in cell hybrids as well as identify candidate
genes involved in the process, either as downstream events or as
primary drivers of gene silencing. Our results show that gene silencing
is widespread, effectively silencing hundreds of genes (both hepato-
ma-speciﬁc and ﬁbroblast speciﬁc) in the cell hybrids. We identiﬁed a
large number of liver-enriched genes (~300) that are silenced in the
hybrid cells. However, these whole genome microarray results
challenge the idea that extinction is global. Previous results (limited
to analysis of well-characterized genes) suggested that all or nearly all
genes that were expressed in one parent cell line but not the otherFig. 7. Potential mechanisms of gene extinction in cell hybrids. In the simplest form, large
resulting in lack-of-activation of HNFs and downstream genes. Alternatively, active repressio
occurring regardless of the presence or absence of these pathways. All proteins shown arewere silenced in cell hybrids. Here, we identiﬁed a large number of
genes (~200–400) that appeared to be cell-speciﬁc yet only modestly
affected in the cell hybrids.
The idea that extinction is bidirectional is reinforced with this
data set, with a large number (~200) of ﬁbroblast speciﬁc genes
found to be silenced. As with the hepatoma-speciﬁc genes, a large
number of ﬁbroblast-speciﬁc genes escaped silencing in the
hybrids. Although mechanisms responsible for gene silencing are
unknown, several conclusions can be drawn from the data set.
First, the fact that silencing of many genes is complete in the cell
hybrids suggest that silencing is maintained efﬁciently. We assume
that cell hybrids have an inherent degree of instability, as has been
observed in several cell hybrid systems. However, the complete
silencing observed indicates that either the hybrids are highly
stable (b1/1000 segregants) or that silencing is strictly maintained
once established. Earlier experiments suggest the second option to
be unlikely, as segregation of chromosomes has been show to
result in complete rescue of hepatic gene expression [12]. Of note is
the degree of silencing that was measured. Many genes were
expressed at robust levels in the parent, yet completely silenced
(as measured by this assay) in the hybrids. For example, several-scale gene silencing could involve repression of a key gene at level 1 (such as Wnt4)
n of a large number of genes at all levels (Wnts, Gh, HNFs, downstream genes) could be
repressed in hepatoma×ﬁbroblast cell hybrids.
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units (background levels).
We attempted to identify candidate genes that might play a
signiﬁcant role in gene silencing. Analyses of hepatic regulatory
circuitry suggest hierarchical expression and combinatorial activa-
tion of target genes [1,6]. Previous data suggest that loss of
expression of some of these transcription factors occurs in hybrids
[32,48]. Indeed, we found nearly complete silencing of some liver-
enriched transcription factors. Foxa2 and Onecut1 were highly
expressed in the hepatoma cells (N3000U) and repressed 30- to 100-
fold in the hybrid cells. HNF4 was expressed at lower levels (250U)
and expression reduced 7-fold in the hybrids. HNF1α, also expressed
at low levels (689U) in hepatoma cells, showed an unexpectedly
modest 3-fold decrease in expression.
We next screened the panel of hepatoma-speciﬁc genes that were
repressed at least 5-fold in the cell hybrids for known gene regulation
activity. We reasoned that genes responsible for the observed
extinction phenotype would likely also be repressed in cell hybrids.
Eight such genes were identiﬁed that encode proteins involved in
gene regulation, including Hhex, Wnt4, an EST withWnt-2 homology,
Wif1, Lef1, Ghrh, Ghr and Igfbp1. Each of these genes weremoderately
to highly expressed in hepatoma cells (600U – 10,000U) but strongly
repressed in the cell hybrids. Interestingly, each of these genes encode
components of one of two pathways: Wnt signaling or the growth
hormone pathway.
Wnt signaling has long been known to play amajor role in key steps
of embryonic development [49]. Recently, several reports have
suggested the wnt pathway to play a key role in development, regener-
ation and cancer of the mammalian liver (reviewed in [50] [51]).
Notably, Wnt signaling has also been shown to play a crucial role in
zebraﬁsh liver development, with a mutation in a Wnt2b homolog
resulting in profound liver defects [52]. Our results showing that several
wnt pathway-related genes (Wnt4, Lef1,Wif1, Hhex) are silenced in the
cell hybrids implicate the involvement of this pathway in establishment
or maintenance of the hepatic phenotype.
While WNT4 and LEF1 are components of the canonical wnt
pathway, WIF1 and HHEX have been reported to be indirectly
involved in wnt signaling. Hhex is a homeodomain transcription
factor that is expressed in the anterior deﬁnitive endoderm [53] and is
essential for proper development in mammals. Loss-of-function Hhex
mice die during embryogenesis with several defects, including altered
liver development [54,55]. Hhex has recently been shown to directly
interact with SOX13, blocking SOX13-mediated repression of theWnt
pathway in mice [56]. Thus, these data suggest that Hhex expression
may be required to drive Wnt4 and Wnt2 gene expression in the
hepatoma cells and that loss of this gene product results in repression
of the these genes. WIF1 was originally shown to bind wnt proteins
and inhibit their activity [57] and subsequently the Wif1 gene was
shown to be subject to epigenetic silencing in several tumor types
[58]. The ﬁnding of several wnt pathway proteins in our analysis
suggests the possibility that disruption of wnt signaling may play a
role in gene silencing observed in these cell hybrids.
GHRH, GHR and IGFBP1 are each components of the growth
hormone pathway that are important in body homeostasis, including
glucose utilization and gluconeogenesis in the liver. Activation of Ghr
by growth hormone results in Jak-STAT pathway activation, resulting
in increased expression of several target genes, including insulin-like
growth factor-1 (Igf1). The role of IGFBP1 has been suggested to both
prevent and promote IGF-1 action [59]. Notably, Lahuna et al. [60]
reported the ability of injected GH to rapidly restore lost expression of
HNF6, HNF4A and Foxa2 in post-hypophysectomized adult rats, thus
suggesting that the growth hormone pathway plays a strong role in
maintaining the regulatory networks in liver.
In conclusion, this whole-genome analysis of the extinction
phenomenon in mammalian cell hybrids indicates that (1) extinction
is bidirectional (both ﬁbroblast and hepatoma-speciﬁc genes expres-sion is affected), (2) dramatic reprogramming of chromatin likely
occurs in the cell hybrids, strongly repressing (5- to 500-fold) a large
number of genes (200–400), (3) several transcription factors are
repressed and (4) a number of tissue-speciﬁc genes escape silencing.
Several models have been proposed to account for gene silencing
in cell hybrids, including active repression and lack-of-activation
[16,17,20]. The results shown here do not rule out either mechanism,
but suggest that the loss of many tissue-speciﬁc transcription factors
is consistent with a lack-of-activation model for many genes.
However, the apparently complete loss of detectable expression of
a large number of genes may suggest that active repression
mechanisms are also functioning to prevent expression of gene
sets. Notably, results by Terranova et al. [61] using myotube×lym-
phocyte hybrids suggest that acquisition and extinction of gene
expression are separate events. In this case, the cell hybrids exhibit a
muscle cell phenotype accompanied with silencing of lymphocyte-
speciﬁc genes, rather than bi-directional silencing.
Although from earlier studies we anticipated the repression of
several HNF genes in the cell hybrids, the prevalence of candidate
genes involved in wnt and gh pathways was unexpected. We suggest
that these pathways may be important in maintenance of overall
hepatic gene expression and thus are perhaps targeted during gene
silencing. It is possible that, due to their role of these pathways in liver
function, that their inactivation may be a key switch leading to
downstream gene silencing (see Fig. 7). Alternatively, gene silencing
may be an active process that targets both upstream and downstream
genes. It will be important to test whether restoration of one or
combinations of these pathways (Wnt, Gh, Hnf) in cell hybrids can
rescue gene expression.
Gene silencing likely includes chromatin remodeling factors,
including histone deacetylases (HDACs) and methytransferases. One
report [61] showed that preventing HDAC activity prevented
extinction of lymphocyte-speciﬁc gene expression. It would be
worthwhile to attempt rescuing cell-speciﬁc gene expression in the
cell hybrids using ectopic expression of genes encoding transcription
factors in conjunction with inhibitors of HDACs in order to initiate
reprogramming of hybrid cells. Such studies could be useful in
identifying key regulatory events leading to gene silencing and the
role they play in normal mammalian development.References
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